National Cancer Institute; Amended Notice of Meeting
---
identifier: "/us/fr/2017-13895"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Cancer Institute; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2017-13895"
section_name: "National Cancer Institute; Amended Notice of Meeting"
positive_law: false
currency: "2017-07-03"
last_updated: "2017-07-03"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2017-13895"
document_type: "notice"
publication_date: "2017-07-03"
agencies:
- "Health and Human Services Department"
- "National Institutes of Health"
fr_citation: "82 FR 30877"
fr_volume: 82
---
# National Cancer Institute; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, July 12, 2017, 11:00 a.m. to July 12, 2017, 3:00 p.m., National Cancer Institute Shady Grove, Shady Grove, 9609 Medical Center Drive, 7W114, Rockville, MD 20850 which was published in the *Federal Register* on May 31, 2017, 82 FR 24983.
The meeting notice is amended to change the meeting title to “Biospecimen and Innovative Technology”. The meeting is closed to the public.
Dated: June 27, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.